Marker Therapeutics, Inc. (MRKR) — 8-K/A Filings
All 8-K/A filings from Marker Therapeutics, Inc.. Browse 1 Amended Current Event Report reports with AI-powered summaries and risk analysis.
8-K/A Filings (1)
-
Marker Therapeutics Files 8-K/A: CMO Departure, New Interim CMO
— Mar 4, 2025 Risk: medium
Marker Therapeutics, Inc. filed an 8-K/A on March 4, 2025, to amend a previous filing regarding the departure of Dr. Robert L. Ferris as Chief Medical Officer,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX